INTUNIV demonstrated symptom reduction on oppositional subscale Conners' ADHD rating scale
Friday, October 30, 2009 - 09:42
in Health & Medicine
HONOLULU - October 29, 2009 -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced new study results on INTUNIV? (guanfacine) Extended Release Tablets, a